CV Sciences acquires encapsulated softgels manufacturer Elevated Softgels
CV Sciences, Inc. (OTCQB:CVSI), a prominent consumer wellness company focusing on hemp extracts and other science-backed natural ingredients, has completed the acquisition of Elevated Softgels, LLC. This acquisition, valued at up to $1,000,000, involves a cash payment of $100,000 at closing, 17,422,181 shares of CV Sciences’ common stock valued at $700,000, and a potential earn-out […]